Fundraising FoxPortal Innovations — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management.
AI & Machine LearningDigital HealthHealthtechMedical DevicesChicago, US
Amit Gupta(Co-founder, Advisor)inMozziyar Etemadi(Co-founder, Head of AI)Omer Inan(Co-founder, Chief Scientific Officer)inAndrew Carek(Co-founder, Chief Technical Officer)inEric Meizlish(Chief Executive Officer)inJohn D. Martin(Chief Medical Officer)in
Co-investorsBayMed Venture PartnersBroadview VenturesCross-Border Impact VenturesLaerdal Million Lives FundOSF VenturesArboretum Ventures+1 more
ClostraBio develops next-generation probiotics and a platform for delivering bacterial metabolites to support gut health, targeting inflammatory bowel disease (IBD) and food allergy.
BiotechDigital HealthHealthtechChicago, US
Jeffrey Hubbell(Secretary)Cathryn Nagler(President)inBrett Newswanger(Chief Operating Officer)
BoardJohn Flavin(Executive Chairman)in
Co-investorsStone Mountain Ventures
Vivtex is a drug development company applying computational science and pre-clinical research to advance new medicines.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
Thomas von Erlach(CEO & Co-founder)inRobert Langer(Co-founder)Giovanni Traverso(Co-founder)inJAMES WINSCHEL(Executive Officer, Director)JUAN LOPEZ(Executive Officer)JACQUES BARBUT(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.